In general, cytokines involved in type 1 immunity including IFNγ, IL-12, and TNFα are shown to orchestrate anti-tumour immune responses against a broad range of cancer types in numerous preclinical and clinical studies [32]. The gene discussed is TNF; the disease is neoplasm.